Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Assessment for effect and safety of Tenofovir Disoproxil Fumarate Tablets in the treatment of hepatitis B: a randomized, double blinding by double simulation, positive agent, multicenter trial

Next Previous
Trial Profile

Assessment for effect and safety of Tenofovir Disoproxil Fumarate Tablets in the treatment of hepatitis B: a randomized, double blinding by double simulation, positive agent, multicenter trial

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 24 Apr 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tenofovir disoproxil fumarate (Primary) ; Adefovir dipivoxil
  • Indications Hepatitis B
  • Focus Therapeutic Use

    • Most Recent Events

    • 29 Jul 2014 Status changed from not yet recruiting to completed as reported by Chinese Clinical Trial Register.
    • 21 May 2012 Planned end date (Nov 2012) added as reported by Chinese Clinical Trial Register.
    • 21 May 2012 Planned initiation date changed from 1 Mar 2010 to 1 Mar 2012 as reported by Chinese Clinical Trial Register.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top